Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Arno Therapeutics, Inc (ARNI)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-15Dec-31-14Dec-31-13Dec-31-12Dec-31-11Dec-31-10Dec-31-09Dec-31-08
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues  0.00.00.00.00.00.05.49.8
            Revenue growth       -100.0%-44.3%236.9%
Cost of goods sold  0.00.00.00.00.00.01.52.3
Gross profit  0.00.00.00.00.00.03.97.5
            Gross margin        72.1%76.3%
Selling, general and administrative   [+]4.86.73.52.32.00.91.52.3
Research and development  8.714.813.58.55.74.1  
Other operating expenses      0.3 9.417.2
EBITDA   [+]-13.4-21.5-16.9-10.8-7.9-5.0-6.9-12.0
            EBITDA margin        -127.6%-123.2%
Depreciation and amortization  0.00.00.00.00.00.00.00.0
EBIT   [+]-13.4-21.5-16.9-10.8-7.9-5.0-7.0-12.1
            EBIT margin        -127.9%-123.7%
Non-recurring items      -0.3   
Interest expense, net   [+]0.00.018.66.40.00.00.00.8
Other income (expense), net  1.929.2-4.22.8-0.31.0  
Pre-tax income  -11.57.8-39.7-14.4-7.9-4.0-6.9-12.9
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -11.57.8-39.7-14.4-8.0-4.3-6.9-12.9
            Net margin        -127.4%-132.2%
   
Basic EPS   [+]($0.56)$0.38($5.28)($3.17)($0.23)($0.21)($0.34)($0.81)
Diluted EPS   [+]($0.56)$0.31($5.28)($3.17)($0.23)($0.21)($0.34)($0.81)
   
Shares outstanding (basic)   [+]20.420.47.54.534.520.420.416.0
Shares outstanding (diluted)   [+]20.424.87.54.534.520.420.416.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy